Health insurance policies; require coverage for certain obesity treatments.
House Bill 360 would require a broad set of health insurance arrangements in Mississippi to cover obesity-related screening, treatment, and related diseases and ailments for covered residents, beginning July 1, 2025. The mandate applies to individual and group health insurance policies, nonprofit health service contracts, HMO contracts, self-insured group arrangements to the extent allowed by federal law, and other managed care entities. Coverage would include treatment for obesity and morbid obesity, including bariatric surgery, gastric bypass, lap band procedures, and prescription treatments, as long as a physician provides a written order stating that the patient’s body mass index is 30% or more above ideal body weight and that the treatment is medically necessary.
The bill also sets cost-sharing and reimbursement rules. It limits deductibles and coinsurance for obesity testing so they cannot exceed the cost-sharing applied to similar benefits, and if no similar benefit exists, the cost-sharing cannot be set so high that it materially reduces the value of the required coverage. It further requires provider reimbursement for covered obesity treatment to be at least equal to Medicare reimbursement levels. The bill does not generally require referrals to out-of-network providers, but if a plan lacks an available and accessible participating provider, it must cover the referred services without extra cost beyond what the patient would pay in-network.
The bill’s impact on state law would be to create a new insurance coverage mandate for obesity treatment and screening, expanding the benefits that regulated health plans must include in Mississippi. It would affect insurers, HMOs, nonprofit health plans, managed care entities, and certain self-insured group plans, while leaving room for federal preemption limits. It would also establish new standards for patient cost-sharing and provider payment for these services.
Available context shows no recorded committee transcript, vote history, or formal action, so there is no documented debate or amendment record to indicate support or opposition. Based on the bill text alone, the measure appears designed to improve access to medically necessary obesity care, suggesting a public-health-oriented purpose. Potential points of contention would likely center on insurance premium impacts, the breadth of the mandate, the medical necessity threshold, and the requirement that reimbursement meet or exceed Medicare levels.
HB360 would amend Mississippi insurance coverage requirements by mandating that specified health plans and related entities cover obesity screening and medically necessary obesity treatment, including certain surgeries and prescriptions, for eligible residents beginning July 1, 2025. It would impose limits on deductibles and coinsurance, require reimbursement at or above Medicare levels, and establish conditions for out-of-network referrals when in-network providers are unavailable. The bill would directly affect insurers, health maintenance organizations, nonprofit health service plans, managed care entities, and some self-insured group arrangements, subject to federal preemption.
There is no committee transcript or vote record available, so the bill’s sentiment cannot be measured from legislative debate or roll calls. The text suggests a generally pro-coverage, pro-access approach aimed at ensuring medically necessary obesity care is available through insurance. In the absence of recorded opposition or support, the bill appears neutral-to-supportive in policy orientation, with likely interest from health advocates and possible caution from insurers.
No specific points of contention are documented in the available materials because there are no transcripts or votes. Based on the bill’s provisions, likely areas of disagreement would include the cost of mandating coverage, whether the BMI/medical-necessity standard is appropriately defined, the inclusion of bariatric procedures and prescriptions, and the requirement that provider reimbursement be at least equal to Medicare. Insurers and employers could view the mandate as increasing premiums, while patient advocates and providers may support it as expanding access to treatment.